Tessera
Folgen

Codon Communications

@codon-comms.bsky.social

We are #lifescience #PR specialists delivering curated solutions for transformational #biotech companies. #messengersinscience

49 Posts27 Follower42 Folgt
BioTechniques@biotechniques.bsky.social · 7mo ago

AI is allowing researchers to dive deeper into both human and ancient biology to look for novel therapeutic molecules. We spoke with @delafuentelab.bsky.social at @elrig.org's DD25 to learn how he has expanded the search for novel antibiotics >>> www.biotechniques.com/computationa... 🧪

Expanding our search for antibiotics: encrypted biology, ancient datasets and AI

We spoke with César de la Fuente to learn how he has developed AI models to discover and design novel antibiotics.

biotechniques.com

BioTechniques@biotechniques.bsky.social · 8mo ago

At @elrig.org’s Drug Discovery 2025, we spoke with Rebecca Goss – Professor at the University of St Andrews and CEO of X-Genix – to learn more about her precision molecular editing platform and what it could mean for drug discovery >>> www.biotechniques.com/bioengineeri... 🧪

Tapping into the precision molecule-editing potential of halogenases

We spoke to Rebecca Goss to learn more about her precision molecular editing platform and its potential for drug development.

biotechniques.com

BioTechniques@biotechniques.bsky.social · 8mo ago

At @elrig.org’s Drug Discovery 2025, we learned about how Yanyan Zhao and her colleagues at the University of Cambridge have approached the preclinical development of a PET imaging tracer to achieve earlier Alzheimer’s disease diagnosis >>> www.biotechniques.com/imaging/prob... 🧪

Probing the brain for answers: a PET tracer for early Alzheimer’s diagnosis

Yanyan Zhao shares an insight into the preclinical development of a PET imaging tracer for catching Alzheimer’s disease earlier.

biotechniques.com

BioTechniques@biotechniques.bsky.social · 9mo ago

In this interview from @elrig.org’s #DD25, @namshik.bsky.social explains quantum algorithms with a London Tube analogy, how they can be applied to benefit drug discovery and his advice for researchers wanting to launch their own startups >>> www.biotechniques.com/computationa...

Quantum questions have algorithmic answers: navigating a drug discovery network

In this interview, Namshik Han explains the role quantum algorithms can play in drug discovery research and what makes a successful startup.

biotechniques.com

BioTechniques@biotechniques.bsky.social · 9mo ago

At @elrig.org’s Drug Discovery 2025, we spoke to Heather Pinkett – President of The Protein Society – to learn more about ABC transporters and what targeting them could mean for combatting antimicrobial resistance >>> www.biotechniques.com/microbiology... 🧪

Targeting ABC to tackle AMR: taking advantage of bacterial membrane proteins

Heather Pinkett tells us about her research investigating ABC transporters in pathogenic bacteria and what this could mean for tackling AMR.

biotechniques.com

BioTechniques@biotechniques.bsky.social · 9mo ago

How paradigm-shifting could an AI-first drug discovery company be? At @elrig.org’s Drug Discovery 2025, we spoke to Miles Congreve, Chief Scientific Officer at @isomorphiclabs.bsky.social, to find out >>> www.biotechniques.com/drug-discove... 🧪

How will AI-first drug design transform human health?

Find out how developments in AlphaFold 3, alongside new predictive models, are changing approaches to drug discovery and design.

biotechniques.com